* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Transfer of NYHA 1-2 Heart Failure Patients to Primary Care
Cardiovascular disease wikipedia , lookup
Remote ischemic conditioning wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Rheumatic fever wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Coronary artery disease wikipedia , lookup
Electrocardiography wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Heart failure wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Croydon Health Service NHS Trust Private and Confidential 16-APR-2015 Clinic Date: 16 APR 2015 MRN: XXXXXXXXXXXX Integrated Heart Failure Specialist Nurses 12 – 18 Lennard Road Croydon CR9 2RS Tel: 020 8274 6416 Fax: 020 8274 6174 Dr XX 20 SATURN ROAD NORBURY LONDON SWXX XXX Dear Dr XX, RE: A PATIENT - DOB XX-DEC-1935 (79 Years) NHS No.XXX XXX XXXX 390 JUPITER AVE. LONDON SWXX XXX TELEPHONE: XXXXXXXXX Transfer of NYHA 1-2 Heart Failure Patients to Primary Care Personalised Management Plan It is the intention of the Croydon CCG Cardiology Implementation Group to transfer the longterm care of patients with Chronic Heart Failure and left ventricular systolic dysfunction with minor or no symptoms (NYHA functional classes 1 and 2) wholly to primary care. Prior to transfer, patients will undergo detailed clinical review by the Croydon Health Services Cardiology and Integrated Heart Failure Nurse Specialist team. This management plan is intended to provide guidance on managing these patients, and establish lines of communication with the Croydon Health Services team for help when required (see attached document). Diagnosis: Heart failure due to poor left ventricular systolic function due to a combination of anteroseptal myocardial infarction and hypertensive heart disease. Heart Failure Code 585F (echocardiogram shows left ventricular systolic dysfunction). Past Medical History/Co-morbidities: Hypertension, Type 2 diabetes. Ischaemic heart disease with old antero-septal myocardial infarction and a further presentation in 2009 in which she underwent primary PCI to the obtuse marginal circumflex with a bare metal stent. At angiography she was found to have an ostially occluded anterior descending and moderate ostial stenosis of the right coronary. Asthma. Echocardiogram (St George's Hospital 20 July 2014): Moderately dilated left ventricle with septal hypertrophy but otherwise normal wall thickness and severe systolic dysfunction (Simpson's bi plane ejection fraction 26%). Moderately dilated right ventricle with preserved systolic function. Moderate bi atrial dilatation. No significant valvular heart disease. Moderate pulmonary hypertension (estimated RV systolic pressure 45-50mm Hg). No pericardial disease. Other Investigations: Cardiac MRI was performed at St George's Hospital on 24 October 2014. This showed a dilated left ventricle with mild concentric hypertrophy and basal septal bulge. Severe systolic LV dysfunction (ejection fraction 35% by MRI). Dysynchronous left ventricular contractility consistent with broad left bundle branch block. Late gadolinium enhancement of the anteroseptal wall consistent with prior infarction. No inducible perfusion defect noted on adenosine stress testing. The extent of ischaemic scar was not sufficient to explain the severity of her LV dysfunction suggesting a combination of both ischaemic heart disease and hypertension as the aetiologies of her heart failure. Bloods 10.2.15: Hb 119g/L, platelets 223, sodium 141, potassium 4.1, urea 6.4, creatinine 67 (eGFR >60ml/min), albumin 39. Other liver function tests normal. TSH (5.9.14) 1.98 (normal). ECG December 2014, St George's Hospital: Sinus rhythm with broad left bundle branch block (QRSD 140ms) and first degree heart block (PR interval 210ms). Ventricular rate 56 bpm. Current Medication: Bisoprolol 5mg od (please reduce this to 2.5mg od), Ramipril 5mg bd, Eplerenone 25mg od, Furosemide 40mg od, ISMN MR 60mg od, Aspirin 75mg od, Atorvastatin 40mg od, Metformin 500mg tds, Chlorpromazine, Orphenadrine, Lansoprazole and Senna. Medication Stopped/Intolerance: Penicillin. Recent Symptoms: This is difficult to determine as she undertakes relatively low levels of physical activity but certainly she is no worse than NYHA Functional Class 2. She is a little fatigued and does report wheezing at times which is relieved by her inhalers. I note two presentations in the last few months to CUH A&E Department with exacerbations of asthma. She denies angina pectoris, dizziness, syncope or palpitations. Heart rate 63 regular, oxygen saturations 95% on room air, blood pressure 140/70 lying and standing. Weight 63.8 kilos. No peripheral oedema. Chest clear to auscultation. Action for GP Please code patient as HF Code 585F (echocardiogram shows left ventricular systolic dysfunction). Necessary (prognostic) medication: She should continue on Ramipril 5mg bd and Eplerenone 25mg od lifelong if tolerated for prognostic benefit. I am concerned her cardioselective beta blocker is exacerbating her asthma a little so I would recommend halving the dose of Bisoprolol to 2.5mg od but not stopping it altogether (again because it delivers prognostic benefit). Blood pressure requires slightly better control and I would recommend initiating Hydralazine 25mg bd in the first instance to achieve this. There is good evidence of its effectiveness also in heart failure patients. If following beta blocker dose reduction her resting heart rate rises to above 70 she will need to start Ivabradine initially at 2.5mg bd aiming for at least 5mg bd and titrated against the heart rate (i.e. to keep it in the 60s). Please consider giving Mrs Ali a separate dosette box containing as required rescue Furosemide in case of deterioration. Further investigation treatment: She currently fits NICE criteria for recommending a biventricular defibrillator implant so I will ask her to be reviewed by our Pacing Devices Consultant Dr Kamdar shortly to go through this with her. Monitoring: Recording of body weight, full blood count, renal biochemistry and clinical review in primary care at least 6-monthly. If you have any concerns please contact the GP Cardiology Advice Line on 020 8401 3000 ext. 4487 Please refer to the Croydon Prescribing Guidelines: www.nhscroydonintranet.croydonpct.nhs.uk/TeamsAndDepartments/primarycarecom missioning/prescribing/Pages/Documents.aspx Action for CHS Cardiology She has probably Class 2 symptoms with heart failure due to poor LV systolic function and broad left bundle branch block and therefore qualifies for a biventricular defibrillator (ICD component for primary prevention). I will ask my colleague Dr Kamdar to see her in his Outpatient Clinic to discuss this with her. Action for Patient We would recommend that you try to improve your levels of physical activity you undertake on a daily basis to keep your heart as fit as possible. It is recommended that you reduced the amount of salt you eat and avoid adding extra salt to your food. Please adhere to a 1.5 litre fluid restriction in 24 hours. Please weigh yourself on a weekly basis and record your weight. If you notice a weight gain of 1.5 kg (2-3 Ibs) in one day make sure you weigh yourself the following day. If your weight continues to rise please contact your GP. A sudden weight gain can indicate fluid retention. Please make a non-urgent appointment within the next 3 weeks to arrange to see your GP to discuss this letter Kind regards and best wishes Yours sincerely Dr Sanjay Kumar Lead Consultant Cardiologist Lilly Mandarano Integrated Heart Failure Nurse CC: Ms A. PATIENT 390 JUPITER AVE. LONDON SWXX XXX Dr Ravi Kamdar Consultant Cardiologist CUH